Incircular’s innovative protein engineering technology, INCYPRO, delivers highly stabilized proteins and protein complexes, capable of improving the properties of proteins for a broad range of applications. INCYPRO combines computational and structural design with selective chemical modification tools, using state-of-the-art crosslinkers, allowing specific reinforcement of the active protein structure with minimal modification.
INCYPRO-stabilized proteins feature a variety of benefits, including:
-Increased thermostability and chemostability
-Reduced aggregation
-Prolonged and improved activity under stress conditions
-Prolonged shelf life
-Stabilized protein complexes, membrane proteins and specific conformations
By offering development projects using our proprietary cutting-edge INCYPRO technology, we generate stabilized proteins & enzymes with applications in the pharmaceutical industry as well as for other industrial processes.
Company Details
- Employees
- 7
- Founded
- -
- Address
- De Boelelaan 1108, Amsterdam,north Holland 1081 Hz,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.incircular.com
- HQ
- Amsterdam, North Holland
Incircular Questions
Incircular's website is http://www.incircular.com
Incircular's LinkedIn profile is https://nl.linkedin.com/company/incircular
Incircular has
7 employees.
View email and phone details for 7
employees at Incircular.
Incircular's industry is
Biotechnology Research
Incircular's top competitors are
Ephion Health,
Predica Diagnostics Bv,
Innocore Pharmaceuticals,
Selectical,
Milo Health,
J&s Preclinical Solutions,
Virxcel,
Seranovo,
Cantoni Therapeutics,
Upyther.
Incircular's categories are Biotechnology Research
Incircular's founding year is 2021
